JP2009518293A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518293A5
JP2009518293A5 JP2008543435A JP2008543435A JP2009518293A5 JP 2009518293 A5 JP2009518293 A5 JP 2009518293A5 JP 2008543435 A JP2008543435 A JP 2008543435A JP 2008543435 A JP2008543435 A JP 2008543435A JP 2009518293 A5 JP2009518293 A5 JP 2009518293A5
Authority
JP
Japan
Prior art keywords
composition
pirfenidone
administration
medicament
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008543435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518293A (ja
JP5175740B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/045750 external-priority patent/WO2007064738A1/en
Publication of JP2009518293A publication Critical patent/JP2009518293A/ja
Publication of JP2009518293A5 publication Critical patent/JP2009518293A5/ja
Application granted granted Critical
Publication of JP5175740B2 publication Critical patent/JP5175740B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008543435A 2005-12-02 2006-11-29 ピルフェニドン療法に付随する有害事象を低減する方法 Active JP5175740B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74197605P 2005-12-02 2005-12-02
US60/741,976 2005-12-02
PCT/US2006/045750 WO2007064738A1 (en) 2005-12-02 2006-11-29 Methods of reducing adverse events associated with pirfenidone therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012187515A Division JP2012229275A (ja) 2005-12-02 2012-08-28 ピルフェニドン療法に付随する有害事象を低減する方法

Publications (3)

Publication Number Publication Date
JP2009518293A JP2009518293A (ja) 2009-05-07
JP2009518293A5 true JP2009518293A5 (enExample) 2009-12-17
JP5175740B2 JP5175740B2 (ja) 2013-04-03

Family

ID=37807840

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008543435A Active JP5175740B2 (ja) 2005-12-02 2006-11-29 ピルフェニドン療法に付随する有害事象を低減する方法
JP2012187515A Withdrawn JP2012229275A (ja) 2005-12-02 2012-08-28 ピルフェニドン療法に付随する有害事象を低減する方法
JP2015002231A Pending JP2015061888A (ja) 2005-12-02 2015-01-08 ピルフェニドン療法に付随する有害事象を低減する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012187515A Withdrawn JP2012229275A (ja) 2005-12-02 2012-08-28 ピルフェニドン療法に付随する有害事象を低減する方法
JP2015002231A Pending JP2015061888A (ja) 2005-12-02 2015-01-08 ピルフェニドン療法に付随する有害事象を低減する方法

Country Status (13)

Country Link
US (1) US20070203202A1 (enExample)
EP (2) EP2316453B1 (enExample)
JP (3) JP5175740B2 (enExample)
AT (1) ATE497766T1 (enExample)
CA (1) CA2631646C (enExample)
CY (1) CY1111355T1 (enExample)
DE (1) DE602006020070D1 (enExample)
DK (1) DK1965797T3 (enExample)
ES (2) ES2385935T3 (enExample)
PL (1) PL1965797T3 (enExample)
PT (1) PT1965797E (enExample)
SI (1) SI1965797T1 (enExample)
WO (1) WO2007064738A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070203202A1 (en) 2005-12-02 2007-08-30 Robinson Cynthia Y Methods of reducing adverse events associated with pirfenidone therapy
EP2124945B1 (en) * 2006-12-18 2011-04-20 Intermune, Inc. Method of providing pirfenidone therapy to a patient
US20080287508A1 (en) * 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
KR101767849B1 (ko) 2007-06-20 2017-08-11 오스펙스 파마슈티칼스, 인코포레이티드 섬유증 저해제로서의 치환된 n-아릴 피리디논
US7635707B1 (en) 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
US7566729B1 (en) 2008-11-10 2009-07-28 Intermune, Inc. Modifying pirfenidone treatment for patients with atypical liver function
SG172981A1 (en) * 2009-01-26 2011-08-29 Intermune Inc Methods for treating acute myocardial infarctions and associated disorders
US8084475B2 (en) 2009-12-04 2011-12-27 Intermune, Inc. Pirfenidone therapy and inducers of cytochrome P450
US7816383B1 (en) 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
DK2670242T3 (da) 2011-01-31 2022-05-02 Avalyn Pharma Inc Aerosolpirfenidon- og pyridonanalogforbindelser og anvendelser deraf
JP2014507474A (ja) * 2011-03-08 2014-03-27 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換n−アリールピリジノン
MX2011007675A (es) * 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
KR102045723B1 (ko) * 2011-09-14 2019-11-18 시오노기 앤드 컴파니, 리미티드 흡입용 의약 조성물
CA2819967C (en) 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
WO2014151517A1 (en) 2013-03-15 2014-09-25 Intermune, Inc. Methods of improving microvascular integrity
NZ722927A (en) 2014-01-10 2022-07-29 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
TWI745396B (zh) 2016-07-12 2021-11-11 日商鹽野義製藥股份有限公司 吸入用醫藥組成物
WO2021107060A1 (ja) * 2019-11-27 2021-06-03 塩野義製薬株式会社 ピルフェニドンの副作用を軽減するための医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839346A (en) * 1972-12-18 1974-10-01 Affiliated Med Res N-substituted pyridone and general method for preparing pyridones
US5310562A (en) * 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
KR100777169B1 (ko) * 2001-01-29 2007-11-16 시오노기세이야쿠가부시키가이샤 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서함유하는 의약 제제
US20070032457A1 (en) * 2003-05-16 2007-02-08 Blatt Lawrence M Combination therapy for cancer treatment
US20070203202A1 (en) 2005-12-02 2007-08-30 Robinson Cynthia Y Methods of reducing adverse events associated with pirfenidone therapy

Similar Documents

Publication Publication Date Title
JP2009518293A5 (enExample)
AU2016201325B2 (en) Methods Of Providing Weight Loss Therapy In Patients With Major Depression
JP7025319B2 (ja) ナルトレキソン療法における薬物バイオアベイラビリティの増加
JP2023086769A (ja) 過体重および肥満を治療する方法
HRP20161444T1 (hr) Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
TW200803857A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
JP2005513107A5 (enExample)
JP2013544290A5 (enExample)
TW200524639A (en) Memantine oral dosage forms
TW201306825A (zh) 狀況治療之改良套裝
JP2013501805A5 (enExample)
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
CN102805746B (zh) 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用
Bailey et al. Prevention and management of postoperative pain in oral surgery
CN110475547A (zh) 治疗多发性硬化症的组合物和方法
JP2019522030A5 (enExample)
Prenner et al. Safety of desloratadine syrup in children six months to younger than 2 years of age: a randomized, double-blinded, placebo-controlled study
American Dental Association ADA dental drug handbook: a quick reference
JP2009539776A (ja) シクロベンザプリンおよびアセクロフェナクの組み合わせを含んでいる薬学的組成物
CN106474095A (zh) 一种用于治疗口腔真菌的口腔粘膜粘贴剂及其制备方法
JP4318899B2 (ja) 抗感冒剤
Ward Ramelteon (Rozerem) for Insomnia.
Loh et al. Adrenaline autoinjectors-what pharmacists need to know
Malungpaishrope Comparative study of efficacy of tramadol/acetaminophen combination tablet and ibuprofen in acute pain control after mandibular third molar surgery
Agent Pr Olopatadine Ophthalmic Solution